Equities

10X Genomics Inc

0A88:LSE

10X Genomics Inc

  • Price (USD)18.50
  • Today's Change0.7272 / 4.09%
  • Shares traded3.51k
  • 1 Year change25.72%
  • Beta2.2414
Data delayed at least 20 minutes, as of Feb 06 2026 17:22 GMT.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
ASSETS
Cash And Short Term Investments393389430
Total Receivables, Net88115104
Total Inventory837482
Prepaid expenses201917
Other current assets, total--02.63
Total current assets584596635
Property, plant & equipment, net310345359
Goodwill, net4.514.514.51
Intangibles, net161723
Long term investments------
Note receivable - long term------
Other long term assets4.133.062.39
Total assets9199651,029
LIABILITIES
Accounts payable131622
Accrued expenses628188
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total433122
Total current liabilities118127131
Total long term debt000
Total debt000
Deferred income tax------
Minority interest------
Other liabilities, total919792
Total liabilities209224223
SHAREHOLDERS EQUITY
Common stock0.000.000.00
Additional paid-in capital2,1782,0261,839
Retained earnings (accumulated deficit)(1467)(1284)(1029)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(0.49)(0.43)(4.34)
Total equity710741806
Total liabilities & shareholders' equity9199651,029
Total common shares outstanding122119115
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.